SEC Form D · filed April 18, 2023
DiaMedica Therapeutics Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (29)
R. M. Giuffre · Minneapolis, MNDirectorDominic Cundari · Minneapolis, MNExecCharles P. Semba · Minneapolis, MNDirectorJames T. Parsons · Minneapolis, MNDirectorScott Kellen · Minneapolis, MNExecTanya N. Lewis · Minneapolis, MNDirectorRick Pauls · Minneapolis, MNExec · DirectorRichard D. Pilnik · Minneapolis, MNDirectorJulie Daves · Minneapolis, MNExecCharles Phillips · New York, NYDirectorKevin Ashton · Lindon, UTDirectorGary D. Reaves, Ii · Stamford, CTExecTodd M. Tomlin · Stamford, CTExec · DirectorJeffrey K. Quake · Stamford, CTExecAndrew S. Tichenor · RICHMOND, VAExecFrancisco D'Souza · New York, NYDirectorJ.W.G. W. Honeybourne · Stamford, CTDirectorJens Ashton · Provo, UTDirectorKirsten Gruis · Minneapolis, MNExecChristopher J. Henderson · Camarillo, CAExecEdward C. Atsinger · Camarillo, CAExecCurtis Burgess · Madison, WIDirectorMatthew Kirk · San Rafael, CAExec · DirectorMichael T. Roth · Greenville, SCDirectorKevin M. Short · Greenville, SCDirectorRichard Goozh · New York, NYExecMartin A. Burian · Vancouver, British Columbia, CanadaDirectorTimothy R. D'Arcy · Boston, MADirectorKirsten Gruis · Minneapolis, MNExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗